Immuneering Corporation
IPOImmuneering | Deep Cyclic Inhibitors for MAPK-Driven Cancers
Immuneering Corporation is a biotech company in Cambridge, United States, founded in 2008. It has raised $25.0M across 1 round, most recently a $25.0M Private Equity in August 2025.
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2008
- Business Model
- B2B
- Website
- immuneering.com
- Total Funding
- $25.0M
- Last Round
- $25.0M Private EquityAug 2025
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. to use credits for reveals, or explore the API.
About
Clinical-stage oncology company developing Deep Cyclic Inhibitors — a new class of cancer therapies targeting MAPK-driven cancers.
Funding & Exit History
Sep 2025
1 more funding event
- Private Equity20251 investor
Funding: Private Equity. Amounts, valuations, and investors where available.
Investors
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
- DevOps ×1
- Marketing & SEO ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immuneering-corporation"><img src="https://indexed.vc/api/badge/company/immuneering-corporation" alt="Immuneering Corporation on Indexed.vc" width="260" height="76" /></a>
